Considerations and barriers to starting a new HAI pump program: An international survey of the HAI Consortium Research Network Journal Article

   


Authors: Cavnar, M.; Ghalambor, T.; Lidsky, M. E.; Dominguez-Rosado, I.; Cho, M.; Karanicolas, P.; Merkow, R.; Mayo, S. C.; Rocha, F. G.; Fields, R. C.; Koerkamp, B. G.; Yopp, A.; Petrowsky, H.; Cercek, A.; Kemeny, N.; Kingham, P.; Jarnagin, W.; Allen, P.; D'Angelica, M.; Gholami, S.
Article Title: Considerations and barriers to starting a new HAI pump program: An international survey of the HAI Consortium Research Network
Abstract: Background: Widespread implementation of HAI pump chemotherapy has been limited by logistic and feasibility concerns. Recent studies demonstrating excellent outcomes have fueled renewed enthusiasm and multiple new programs have emerged. This survey aims to identify barriers critical to establish a successful HAI program. Methods: Using SurveyMonkeyTM, a 17-question survey assessing factors required for establishing a successful program was developed by 12 HAI Consortium Research Network (HCRN) surgical oncologists. Content analysis was used to code textual responses. Frequency of categories and average rank scores for each choice were calculated. Results: Twenty-eight HCRN members responded to the survey. Implementation time varied, with 15 institutions requiring less than a year. Most programs (n = 17) became active in the past 5 years. Medical and surgical oncology were ranked most important for building a program (average ranking scores: 7.96 and 6.59/8). Administrative or regulatory approval was required at half of the institutions. The top 3 challenges faced when building a program were related to regulatory approval (6.65/9), device/equipment access (6.33/9), and drug (FUDR) access (6.25/9). Conclusion: Development of successful programs outside of historically established centers is feasible and requires a multidisciplinary team. Future collaborative efforts are critical for sustainability of safe/effective new programs. © 2022 International Hepato-Pancreato-Biliary Association Inc.
Keywords: health program; questionnaire; intraarterial drug administration; brachytherapy; health care planning; hepatic artery; content analysis; surgical volume; health care survey; surgical oncology; humans; human; male; female; article; surgical oncologist; multidisciplinary team; surveys and questionnaires; device shortage
Journal Title: HPB
Volume: 24
Issue: 12
ISSN: 1365-182X
Publisher: Elsevier Science, Inc.  
Date Published: 2022-12-01
Start Page: 2104
End Page: 2111
Language: English
DOI: 10.1016/j.hpb.2022.08.008
PUBMED: 36085262
PROVIDER: scopus
PMCID: PMC9771984
DOI/URL:

https://www.scopus.com/inward/record.uri?eid=2-s2.0-85137413026&doi=10.1016%2fj.hpb.2022.08.008&partnerID=40&md5=310ead63183c2b522b4b3599e0cf02f7
Notes: Article -- Export Date: 3 January 2023 -- Source: Scopus
Altmetric
What is Altmetric?
Citation Impact
What is Dimensions Citation Badge?
BMJ Impact Analytics
MSK Authors
  1. Andrea Cercek Hanjis
    351 Cercek Hanjis
  2. William R Jarnagin
    903 Jarnagin
  3. Michael D'Angelica
    777 D'Angelica
  4. T Peter Kingham
    609 Kingham
  5. Nancy Kemeny
    543 Kemeny
Related MSK Work